Overexpression of IDE in APP transgenic mice reduced brain Aβ levels and prevented Aβ plaque formation [54] and an IDE gene variant associated with elevated IDE expression was associated with reduced plasma Aβ levels and decreased risk of late-onset AD [55]. This evidence concerns the gene APP and Alzheimer disease.